Cargando…
Classifying Oligometastatic Non-Small Cell Lung Cancer
SIMPLE SUMMARY: Around half of patients with non-small cell lung cancer (NSCLC) have metastatic disease at the time of diagnosis. Some patients will have a limited number of metastatic sites, termed oligometastasis, rather than widespread disease. Aggressive treatment of oligometastasis has been sup...
Autores principales: | Blumenthaler, Alisa N., Antonoff, Mara B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507821/ https://www.ncbi.nlm.nih.gov/pubmed/34638306 http://dx.doi.org/10.3390/cancers13194822 |
Ejemplares similares
-
Commentary: When does the burden of treatment outweigh the biological benefit?
por: Blumenthaler, Alisa N., et al.
Publicado: (2020) -
Oligometastatic Disease in Non-Small-Cell Lung Cancer: An Update
por: Chen, Yi-Hsing, et al.
Publicado: (2022) -
Oligometastatic non-small cell lung cancer: Current management
por: Román-Jobacho, Alicia, et al.
Publicado: (2021) -
Oligometastatic non-small-cell lung cancer: current treatment strategies
por: Richard, Patrick J, et al.
Publicado: (2016) -
Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer
por: Santos, Patricia Mae G., et al.
Publicado: (2022)